Therapy topoisomerase ii inhibitors. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Tumor Cells, Cultured KB Cells Cell Line Chromosomes, Human, Pair 11 Cell Line, Tumor HL-60 Cells HeLa Cells Cell Nucleus Chromosomes

Organisms4

Cricetinae Cricetulus Crithidia fasciculata Saccharomyces cerevisiae

Diseases11

Leukemia P388 Neoplasms, Second Primary Leukemia, Radiation-Induced Translocation, Genetic Leukemia, Myeloid Leukemia Myelodysplastic Syndromes Leukemia L1210 Chromosome Aberrations Leukemia, Myeloid, Acute Neoplasms

Chemicals and Drugs46

Topoisomerase II Inhibitors DNA Topoisomerases, Type II Teniposide Amsacrine Topoisomerase I Inhibitors Etoposide Ellipticines DNA Topoisomerases, Type I Razoxane Topoisomerase Inhibitors Novobiocin Podophyllotoxin Thiobarbiturates Intercalating Agents Enzyme Inhibitors Camptothecin Antineoplastic Agents, Phytogenic Aclarubicin Aminoacridines Antineoplastic Agents Doxorubicin DNA Mitoxantrone Antigens, Neoplasm Myeloid-Lymphoid Leukemia Protein DNA-Binding Proteins Nucleic Acid Synthesis Inhibitors DNA Topoisomerase IV Antibiotics, Antineoplastic DNA, Superhelical DNA, Neoplasm Topotecan Piperazines Daunorubicin DNA, Catenated Heterocyclic Compounds with 4 or More Rings Anthraquinones DNA Topoisomerases DNA, Kinetoplast Isoenzymes Cisplatin Tumor Suppressor Protein p53 DNA Gyrase Quinolones Naphthalimides Transcription Factors

Analytical, Diagnostic and Therapeutic Techniques and Equipment1

Drug Screening Assays, Antitumor

Phenomena and Processes28

DNA Damage DNA, Superhelical Drug Resistance Cell Cycle Cell Survival G2 Phase Apoptosis Drug Resistance, Neoplasm DNA, Catenated Base Sequence Mitosis DNA Cleavage Translocation, Genetic Chromosomes, Human, Pair 11 DNA Repair Proto-Oncogenes Drug Interactions Dose-Response Relationship, Drug Cell Division Chromosome Aberrations DNA Replication Nucleic Acid Conformation Kinetics Chromosomes Time Factors Catalysis Mutation Plasmids

Information Science2

Base Sequence Molecular Sequence Data

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science

Topoisomerase II Inhibitors DNA Topoisomerases, Type II Teniposide Amsacrine Topoisomerase I Inhibitors Etoposide Ellipticines DNA Topoisomerases, Type I Razoxane Topoisomerase Inhibitors Novobiocin Podophyllotoxin Thiobarbiturates Intercalating Agents Enzyme Inhibitors Camptothecin DNA Damage Antineoplastic Agents, Phytogenic Aclarubicin Aminoacridines Antineoplastic Agents Doxorubicin DNA Mitoxantrone Antigens, Neoplasm Myeloid-Lymphoid Leukemia Protein Tumor Cells, Cultured DNA-Binding Proteins Nucleic Acid Synthesis Inhibitors DNA Topoisomerase IV Antibiotics, Antineoplastic DNA, Superhelical Drug Screening Assays, Antitumor Drug Resistance Leukemia P388 DNA, Neoplasm Topotecan Cell Cycle Cell Survival Cricetinae Neoplasms, Second Primary KB Cells G2 Phase Piperazines Apoptosis Daunorubicin Drug Resistance, Neoplasm Leukemia, Radiation-Induced DNA, Catenated Base Sequence Cricetulus Cell Line Heterocyclic Compounds with 4 or More Rings Mitosis DNA Cleavage Molecular Sequence Data Anthraquinones Translocation, Genetic Chromosomes, Human, Pair 11 Cell Line, Tumor DNA Repair Leukemia, Myeloid HL-60 Cells Leukemia HeLa Cells DNA Topoisomerases DNA, Kinetoplast Proto-Oncogenes Isoenzymes Drug Interactions Myelodysplastic Syndromes Dose-Response Relationship, Drug Cell Division Leukemia L1210 Chromosome Aberrations Crithidia fasciculata Leukemia, Myeloid, Acute Cisplatin Cell Nucleus Tumor Suppressor Protein p53 DNA Replication Nucleic Acid Conformation DNA Gyrase Quinolones Kinetics Chromosomes Naphthalimides Time Factors Transcription Factors Catalysis Saccharomyces cerevisiae Mutation Neoplasms Plasmids

No FAQ available that match "therapy topoisomerase ii inhibitors"